Key Findings of the Global Prosthetic Heart Valves Market | Technavio

Technavio has published a new market research report on the global prosthetic heart valves market from 2018-2022.

LONDON--()--The latest market research report by Technavio on the global prosthetic heart valves market predicts a CAGR of above 12% during the period 2018-2022.

The report segments the global prosthetic heart valves market by product (transcatheter heart valves, tissue heart valves, and mechanical heart valves), by end-user (hospitals and ASCs), and by geography (the Americas, EMEA, and APAC). It provides a detailed illustration of the major factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Here are some key findings of the global prosthetic heart valves market, according to Technavio healthcare and life sciences researchers:

  • Growing prevalence of heart-related disorders: a major market driver
  • Emergence of MRI-conditional heart valves: emerging market trend
  • EMEA dominated the global prosthetic heart valves market with 46% share in 2017
  • In 2017, transcatheter heart valves held the highest market share of nearly 64%

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

Growing prevalence of heart-related disorders: a major market driver

Various chronic heart valve-related disorders such as cardio valvular diseases and valvular and heart failure are on the rise. Additionally, some of the other complications indirectly contributing to the market growth are prosthetic valve thrombosis, mechanical hemolytic anemia, prosthetic valve endocarditis, and thromboembolism. Globally, the demand for cardiac prosthetic devices has increased further due to other major clinical complications such as stroke, rhythm disorder, congenital heart disease, subclinical atherosclerosis, heart failure, and peripheral arterial disease. Further, the obstruction in blood flow will also contribute to the market growth.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Emergence of MRI-conditional heart valves: emerging market trend

The ongoing technological advances in repair/replacement of abnormal heart valves are driving the development of innovative prosthetic heart valves. At the same time, technological innovations in both diagnosis and treatment of patients with abnormal heart valves have created the need for novel prosthetic heart valves that aid in improving the quality of life and life expectancy. The prosthetic heart valves technology has undergone multiple evolutions to meet the unmet needs of patients. Thus, players in the market have been investing a significant amount in R&D activities, which led to the development of MRI-conditional heart valves.

According to a senior analyst at Technavio for research on cardiovascular devices, “During the procedural examination, MRI-conditional heart valves help to improve the visibility of the heart valve. Regulatory approval of the MRI-conditional heart valve is expected to change the market dynamics. The advent of this new technology will further expand the ability to access heart valves with diagnostic capabilities of MRI. Further, the new interior-mounted leaflet and frame design help in enhancing durability.”

Global market opportunities

In terms of regional dominance, EMEA led the global prosthetic heart valves market, followed by the Americas and APAC in 2017. In EMEA, countries such as Germany, the UK, France, Italy, and Spain were the major revenue contributors to the prosthetic heart valves market. There has been rapid growth of the market in these countries. The key drivers of the market in this region are the increasing older adult population and growing incidence of heart valve diseases.

 

Technavio’s best deals of the month!

Technavio supports Health for All campaign on this World Health Day with 20% savings on all reports in the Health and Wellness category for the entire month.

OR

Celebrate International Astronomy Day by indulging in a whopping 30% savings on all reports in the Space category. Offer valid from 16th April for a limited period.

 

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The latest market research report by Technavio on the global prosthetic heart valves market predicts a CAGR of above 12% during the period 2018-2022.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com